1. Standard Oil Co. of New Jersey v. United States. 1911. 221 U.S. 1, 31 S. Ct. 502.
2. Food and Drug Administration. December 30, 2009. “NDA 22-272 OxyContin Division Director Summary Review for Regulatory Action.” 10 (emphasis added). Available at https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022272s000MedR.pdf.
3. Dudley, Susan E. Summer 2013. “OMB’s Reported Benefits of Regulation: Too Good to Be True?” In Regulation: Cato Institute 26–30.
4. The Costs and Benefits of Regulation: Review and Synthesis;Hahn;Yale Journal on Regulation,1990